X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (113) 113
index medicus (94) 94
female (80) 80
middle aged (79) 79
liver transplantation (78) 78
male (78) 78
life sciences (71) 71
gastroenterology & hepatology (65) 65
transplantation (65) 65
liver (54) 54
adult (52) 52
aged (38) 38
surgery (36) 36
risk factors (34) 34
hepatitis c (33) 33
cirrhosis (32) 32
human health and pathology (32) 32
hepatitis (28) 28
treatment outcome (28) 28
recurrence (26) 26
gastroenterology and hepatology (24) 24
liver transplantation - adverse effects (24) 24
retrospective studies (24) 24
france (21) 21
liver diseases (21) 21
survival (21) 21
ribavirin (20) 20
therapy (20) 20
hepatocellular carcinoma (18) 18
prospective studies (18) 18
recipients (18) 18
hepatitis c, chronic - drug therapy (17) 17
time factors (17) 17
transplants & implants (17) 17
antiviral agents - therapeutic use (16) 16
drug therapy, combination (16) 16
hepatitis c virus (16) 16
hépatology and gastroenterology (16) 16
multivariate analysis (16) 16
patients (16) 16
[sdv]life sciences [q-bio] (15) 15
immunosuppression (15) 15
syngeneic grafts (15) 15
allografts (14) 14
cancer (14) 14
care and treatment (14) 14
follow-up studies (14) 14
infection (14) 14
mortality (14) 14
risk (14) 14
liver cancer (13) 13
liver transplantation - mortality (13) 13
adolescent (12) 12
disease (12) 12
genotype (12) 12
immunosuppressive agents - therapeutic use (12) 12
impact (12) 12
interferon (12) 12
pharmacology & pharmacy (12) 12
[sdv.mhep.heg]life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (11) 11
antiviral agents (11) 11
carcinoma, hepatocellular - pathology (11) 11
efficacy (11) 11
fibrosis (11) 11
liver cirrhosis (11) 11
prognosis (11) 11
relapse (11) 11
[ sdv ] life sciences [q-bio] (10) 10
analysis (10) 10
chemical and drug induced liver injury - etiology (10) 10
epidemiology (10) 10
follow-up (10) 10
immunology (10) 10
incidence (10) 10
infections (10) 10
infectious diseases (10) 10
liver neoplasms - pathology (10) 10
risk assessment (10) 10
survival analysis (10) 10
sustained virological response (10) 10
virus-infection (10) 10
young adult (10) 10
antiviral agents - adverse effects (9) 9
calcineurin inhibitors (9) 9
hepatitis c, chronic - complications (9) 9
liver transplantation - methods (9) 9
medical research (9) 9
safety (9) 9
tacrolimus (9) 9
virus diseases (9) 9
waiting lists (9) 9
abridged index medicus (8) 8
carcinoma, hepatocellular - mortality (8) 8
carcinoma, hepatocellular - surgery (8) 8
chronic hepatitis-c (8) 8
drug therapy (8) 8
hcv infection (8) 8
health aspects (8) 8
hepatology (8) 8
liver neoplasms - mortality (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Safety, ISSN 0114-5916, 2/2013, Volume 36, Issue 2, pp. 135 - 144
Journal Article
Liver International, ISSN 1478-3223, 12/2018, Volume 38, Issue 12, pp. 2170 - 2177
Journal Article
Liver Transplantation, ISSN 1527-6465, 10/2016, Volume 22, Issue 10, pp. 1367 - 1378
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 03/2014, Volume 60, Issue 3, pp. 579 - 589
Journal Article
World Journal of Surgery, ISSN 0364-2313, 8/2017, Volume 41, Issue 8, pp. 2101 - 2110
Journal Article
Transplantation, ISSN 0041-1337, 08/2016, Volume 100, Issue 8, pp. 1705 - 1713
BACKGROUND:We conducted a randomized multicenter open-label trial in de novo liver transplant recipients to assess the feasibility and potential benefit of a... 
Life Sciences | Human health and pathology | Immunology | Surgery
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 10/2019, Volume 25, Issue 19, pp. 5859 - 5865
Purpose: Macrotrabecular-massive hepatocellular carcinoma (MTM-HCC) is a novel morphological subtype of HCC associated with early relapse after resection or... 
SURVIVAL | PATHWAYS | CELLS | VESSELS | ANGIOGENESIS | ONCOLOGY | GENES | ENDOCAN EXPRESSION | VEGF-A
Journal Article
Journal Article
BMC CANCER, ISSN 1471-2407, 05/2010, Volume 10, Issue 1, pp. 190 - 190
Background: The potential anti-cancer effects of mammalian target of rapamycin (mTOR) inhibitors are being intensively studied. To date, however, few... 
RAPAMYCIN | TARGET | THERAPY | TUMOR PROGRESSION | EFFICACY | ONCOLOGY | MODEL | CANCER | RENAL-CELL CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | CYCLOSPORINE | Recurrence | Carcinoma, Hepatocellular - mortality | Prospective Studies | Liver Transplantation - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Intracellular Signaling Peptides and Proteins - metabolism | Liver Neoplasms - mortality | Transplantation, Homologous | Carcinoma, Hepatocellular - drug therapy | Time Factors | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Liver Neoplasms - enzymology | Protein-Serine-Threonine Kinases - metabolism | Sirolimus - therapeutic use | Europe | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Risk Factors | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Liver Transplantation - mortality | Treatment Outcome | Carcinoma, Hepatocellular - enzymology | Canada | Disease-Free Survival | TOR Serine-Threonine Kinases | Australia | Liver cancer | Care and treatment | Immunotherapy | Liver | Organ transplant recipients | Transplantation | Hepatoma | Diagnosis | Research | Health aspects | Liver Transplantation | Carcinoma | Immunosuppressive Agents | Sirolimus | Protein-Serine-Threonine Kinases | Liver Neoplasms | Homologous | Surgery | drug therapy | Intracellular Signaling Peptides and Proteins | Kirurgi | enzymology | antagonists & inhibitors | Hepatocellular | mortality | adverse effects | metabolism | Cancer and Oncology | therapeutic use | Cancer och onkologi
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 2017, Volume 75, Issue 1, pp. 97 - 107
Journal Article
Liver Transplantation, ISSN 1527-6465, 04/2015, Volume 21, Issue 4, pp. 512 - 523
Journal Article